Oncolytics Biotech’s virus-based anti-cancer therapy Reolysin (pelareorep) has the attention of top researchers from Winship Cancer Center and City of Hope who are studying how combinations including pelareorep and Kyprolis (carfilzomib) offer benefits to multiple myeloma patients.
Free access provides up to 10 articles
Subscription options start at $5 per month
which is less than a Starbucks coffee!